|
|
Blood, 15 November 2004, Vol. 104, No. 10, pp. 3326-3334.
Prepublished online as a Blood First Edition Paper on July 29, 2004; DOI 10.1182/blood-2003-04-1197.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression
Alexey Ushmorov,
Olga Ritz,
Michael Hummel,
Frank Leithäuser,
Peter Möller,
Harald Stein, and
Thomas Wirth
From the Department of Physiological Chemistry and Department of Pathology, University of Ulm, Ulm, Germany; and Institute of Pathology, Consultation and Reference Center for Lymph Node Pathology and Haematopathology, Charité-University Medicine, Campus Benjamin Franklin, Free University, Berlin, Germany.
Immunoglobulin production is impaired in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) in spite of functional clonal rearrangements. The presence of "crippling" mutations in coding and regulatory regions, as well as down-regulation of B-cell-specific transcription factors, has been suggested as a potential reason for the lack of immunoglobulin (Ig) chain gene transcription. We have investigated the impact of epigenetic silencing in suppressing Ig heavy (H)-chain expression. Chromatin immunoprecipitation (ChIP) was used to analyze transcription factor binding to octamer motifs present in the IgH regulatory regions. Transcription factors were bound to these motifs in control cell lines, however, they were absent in the cHL-derived cell lines KMH2, L1236, and L428. Ectopic expression of octamer-binding transcription factor (Oct2) and/or B-cell Oct binding protein/Oct-binding factor (BOB.1/OBF.1) did not result in any measurable binding to these sites. Increased histone 3 Lysine 9 (H3-K9) methylation was observed in the promoter region of the IgH locus in L428 and L1236 cells. This is a typical feature of heterochromatic, transcriptionally silent regions. Treatment of cHL-derived cell lines with the DNA demethylating agent 5-aza-2'-deoxycytidine (5-aza-dC) partially reactivated IgH transcription and affected chromatin modifications. Our results suggest an important role of epigenetic silencing in the inhibition of IgH transcription in HRS cells. (Blood. 2004;104:3326-3334)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. Buglio, G. V. Georgakis, S. Hanabuchi, K. Arima, N. M. Khaskhely, Y.-J. Liu, and A. Younes
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
Blood,
August 15, 2008;
112(4):
1424 - 1433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. A. Scheeren, S. A. Diehl, L. A. Smit, T. Beaumont, M. Naspetti, R. J. Bende, B. Blom, K. Karube, K. Ohshima, C. J. M. van Noesel, et al.
IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis
Blood,
May 1, 2008;
111(9):
4706 - 4715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Navarro, A. Gaya, A. Martinez, A. Urbano-Ispizua, A. Pons, O. Balague, B. Gel, P. Abrisqueta, A. Lopez-Guillermo, R. Artells, et al.
MicroRNA expression profiling in classic Hodgkin lymphoma
Blood,
March 1, 2008;
111(5):
2825 - 2832.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Akimzhanov, L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, et al.
Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling
Am. J. Pathol.,
January 1, 2008;
172(1):
215 - 224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Kapatai and P Murray
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma
J. Clin. Pathol.,
December 1, 2007;
60(12):
1342 - 1349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I. Martin-Subero, W. Klapper, A. Sotnikova, E. Callet-Bauchu, L. Harder, C. Bastard, R. Schmitz, S. Grohmann, J. Hoppner, J. Riemke, et al.
Chromosomal Breakpoints Affecting Immunoglobulin Loci Are Recurrent in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Cancer Res.,
November 1, 2006;
66(21):
10332 - 10338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I. Martin-Subero, I. Wlodarska, C. Bastard, J.-M. Picquenot, J. Hoppner, M. Giefing, W. Klapper, R. Siebert, S. Mathas, S. Joos, et al.
Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma.
Blood,
July 1, 2006;
108(1):
401 - 403.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ushmorov, F. Leithauser, O. Sakk, A. Weinhausel, S. W. Popov, P. Moller, and T. Wirth
Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma
Blood,
March 15, 2006;
107(6):
2493 - 2500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chaganti, A. I. Bell, N. B. Pastor, A. E. Milner, M. Drayson, J. Gordon, and A. B. Rickinson
Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes
Blood,
December 15, 2005;
106(13):
4249 - 4252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Coupland, C. Loddenkemper, J. R. Smith, R. M. Braziel, F. Charlotte, I. Anagnostopoulos, and H. Stein
Expression of Immunoglobulin Transcription Factors in Primary Intraocular Lymphoma and Primary Central Nervous System Lymphoma
Invest. Ophthalmol. Vis. Sci.,
November 1, 2005;
46(11):
3957 - 3964.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kempe, H. Kestler, A. Lasar, and T. Wirth
NF-{kappa}B controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program
Nucleic Acids Res.,
September 21, 2005;
33(16):
5308 - 5319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Re, R. Kuppers, and V. Diehl
Molecular Pathogenesis of Hodgkin's Lymphoma
J. Clin. Oncol.,
September 10, 2005;
23(26):
6379 - 6386.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
